Gene · 4824
Papers3,429
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 3,429
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The implications for urological malignancies of non-coding RNAs in the the tumor microenvironment. | Comput Struct Biotechnol J | 2024 | 38249783 | PubTator, text mining | PubMed |
| Advancements in drug-loaded hydrogel systems for bone defect repair. | Regen Ther | 2024 | 38230308 | PubTator, text mining | PubMed |
| Recent developments in sunscreens based on chromophore compounds and nanoparticles. | RSC Adv | 2024 | 38226149 | PubTator, text mining | PubMed |
| Elinzanetant: a phase III therapy for postmenopausal patients with vasomotor symptoms. | Expert Opin Investig Drugs | 2024 | 38224099 | PubTator, text mining | PubMed |
| Symptomatic Benign Prostatic Hyperplasia with Suppressed Epigenetic Regulator HOXB13 Shows a Lower Incidence of Prostate Cancer Development. | Cancers (Basel) | 2024 | 38201640 | PubTator, text mining | PubMed |
| A case report of challenges in distinguishing gastroesophageal junction hepatoid adenocarcinoma from testicular germ cell tumor: Insights for improved diagnosis with gene expression profiling. | SAGE Open Med Case Rep | 2024 | 38187811 | PubTator, text mining | PubMed |
| A carboxy-terminal ubiquitylation site regulates androgen receptor activity. | Commun Biol | 2024 | 38182874 | PubTator, text mining | PubMed |
| Laparoscopic total pelvic exenteration combined with transanal total mesorectal excision for locally advanced prostate cancer with rectal infiltration. | IJU Case Rep | 2024 | 38173461 | PubTator, text mining | PubMed |
| Mucin-producing urothelial-type adenocarcinoma of the prostate with sarcomatoid features and novel molecular phenotype. | IJU Case Rep | 2024 | 38173453 | PubTator, text mining | PubMed |
| The role of the methyltransferase METTL3 in prostate cancer: a potential therapeutic target. | BMC Cancer | 2024 | 38166703 | PubTator, text mining | PubMed |
| Female Hyperplastic PSA-Positive Prostate Tissue in the Bladder Neck. | Urol Int | 2024 | 38056438 | PubTator, text mining | PubMed |
| Immunohistochemical and Molecular Characteristics of Anogenital Papillary Hidradenomas. | Am J Dermatopathol | 2024 | 38055985 | PubTator, text mining | PubMed |
| Endocrine nuclear receptors and long non‑coding RNAs reciprocal regulation in cancer (Review). | Int J Oncol | 2024 | 38038050 | PubTator, text mining | PubMed |
| UBE2J1 is the E2 ubiquitin-conjugating enzyme regulating androgen receptor degradation and antiandrogen resistance. | Oncogene | 2024 | 38030789 | PubTator, text mining | PubMed |
| Aberrant expression of GATA3 in metastatic adenocarcinoma of the prostate: an important pitfall. | Histopathology | 2024 | 37965687 | PubTator, text mining | PubMed |
| Acquired copy number variation in prostate tumours: a review of common somatic copy number alterations, how they are formed and their clinical utility. | Br J Cancer | 2024 | 37945750 | PubTator, text mining | PubMed |
| Characterization of HOXB13 expression patterns in localized and metastatic castration-resistant prostate cancer. | J Pathol | 2024 | 37850574 | PubTator, text mining | PubMed |
| Positive NKX3.1 as a diagnostic pitfall for prostate cancer in extramammary Paget's disease of genitourinary sites. | Histopathology | 2024 | 37794658 | PubTator, text mining | PubMed |
| Metformin Overcomes the Consequences of NKX3.1 Loss to Suppress Prostate Cancer Progression. | Eur Urol | 2024 | 37659962 | PubTator, text mining | PubMed |
| Immunohistochemical Characterization of a Large Cohort of Triple Negative Breast Cancer. | Int J Surg Pathol | 2024 | 37306115 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4824/papers?page=10